Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
SBFMW SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)
0.4200.0000.00%
Close
01/27 16:00 ET
High
0.000
Open
0.420
Turnover
0.00
Low
0.000
Pre Close
0.420
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Sunshine Biopharma Announces Share Repurchase Program
MONTREAL, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includ
Sunshine Biopharma Enters Into a Collaboration Agreement With a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer MRNA Project
MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas, inclu
Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral dr
EXCLUSIVE: Sunshine Biopharma Says 'The Addition of Nora Pharma Allows Sunshine Biopharma to Expand Its Operations Into the Area of Generic Prescription Drugs and Biosimilars'
EXCLUSIVE: Sunshine Biopharma Says 'The addition of Nora Pharma allows Sunshine Biopharma to expand its operations into the area of generic prescription drugs and biosimilars'
EXCLUSIVE: Sunshine Biopharma Tells Benzinga Co. Announces The Acquisition Of Nora Pharma For $21M In Cash, Common Stock, And An Earn-Out Amount
EXCLUSIVE: Sunshine Biopharma Tells Benzinga Co. Announces The Acquisition Of Nora Pharma For $21M In Cash, Common Stock, And An Earn-Out Amount
Sunshine Biopharma Files Its Second Quarter Report With the SEC
Company Reports Significant Increase in Cash on Hand as a Result of Recent FinancingsMONTREAL, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW"), a pharmaceutic
Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW") (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral dr
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW") (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, developm
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW"), a pharmaceutical company focused on the research, development and commercialization of oncology an
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer TreatmentsMONTREAL, April 05, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW"), a pharmaceutical c
Company Overview
More
Sunshine Biopharma, Inc. engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. Its products include treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Pointe-Claire, Canada.
CEO： Dr. Steve N. Slilaty, PhD
Market： NASDAQ
Listing Date： 02/15/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet